Heartrate Variability During Conventional and Variable Pressure Support Mechanical Ventilation
1 other identifier
interventional
30
1 country
1
Brief Summary
Rationale Studies show that about a third of all postoperative complications are due to cardiovascular reasons. Furthermore it was shown that more than 50% of postoperative deaths are associated with severe cardiovascular incidents. After surgical interventions seriously ill patients are transferred to intensive care units and mechanically ventilated. However there is not much evidence about the impact of mechanical ventilation on the cardiovascular system and cardiovascular complications. Artificial mechanical ventilation greatly differs from physiological breathing. In contrast to physiological negative pressure ventilation of th lung, mechanical positive pressure ventilation can cause ventilator induced lung injuries. Furthermore a significant deterioration of lung-heart-interaction during mechanical ventilation is known. Relevance Mechanical ventilation leads to a decreased heartrate-variability, which has to be understood as increased stress on the cardiovascular system. Recently, a new ventilation mode called "variable pressure support ventilation" (VPSV) also known as "noisy pressure support ventilation". This new ventilation mode is similar to the ventilator mode "spontaneous-continuous positive airway pressure/pressure support" (SPN-CPAP), which is often used in a intensive care unit routine. Though VPSV differs through varying applicated pressure support and therefore tidal volumes. Therefore the new ventilation mode rather imitates physiological situation, since tidal volumes vary in physiological breathing, which has positive impact on heart-lung-interaction.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2018
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 22, 2017
CompletedFirst Posted
Study publicly available on registry
December 4, 2017
CompletedStudy Start
First participant enrolled
February 6, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2020
CompletedApril 8, 2020
April 1, 2020
2.8 years
November 22, 2017
April 7, 2020
Conditions
Outcome Measures
Primary Outcomes (1)
HF components
High frequency (HF) components of heartrate-variability in ms²
2 hours
Secondary Outcomes (3)
SDNN
2 hours
HF-LF-ratio
2 hours
Tidal volumes
2 hours
Other Outcomes (3)
pH
At minute 5, 55, 65 and 115 of the measurement
PaO2
At minute 5, 55, 65 and 115 of the measurement
PaCO2
At minute 5, 55, 65 and 115 of the measurement
Study Arms (2)
Treatment A-B
EXPERIMENTALPatient is treated with 1 hour SPN-CPAP/PS followed by 1 hour of Variable-PS ventilation mode
Treatment B-A
EXPERIMENTALPatient is treated with 1 hour Variable-PS followed by 1 hour of SPN-CPAP/PS ventilation mode
Interventions
Eligibility Criteria
You may qualify if:
- patients undergoing therapy at an ICU; patients intubated and ventilated using SPN-CPAP/PS ventilator mode; patients with sinus rhythm in electrocardiogram
You may not qualify if:
- patients with active heart pace maker / defibrillator; patients with absent sinus rhythm in electrocardiogram; patients with known severe disease of autonomous nervous system
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Medical University of Viennalead
- Vienna University of Technologycollaborator
Study Sites (1)
Medical University of Vienna
Vienna, 1090, Austria
Study Officials
- PRINCIPAL INVESTIGATOR
Maximlian Schnetzinger, BSc
Medical University of Vienna
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- TREATMENT
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 22, 2017
First Posted
December 4, 2017
Study Start
February 6, 2018
Primary Completion
December 1, 2020
Study Completion
December 31, 2020
Last Updated
April 8, 2020
Record last verified: 2020-04